These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis. La Nasa G; Littera R; Cocco E; Battistini L; Marrosu MG; Contu L Ann Hematol; 2004 Jun; 83(6):403-5. PubMed ID: 14648027 [TBL] [Abstract][Full Text] [Related]
4. Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks. Capello E; Vuolo L; Gualandi F; Van Lint MT; Roccatagliata L; Bonzano L; Pardini M; Uccelli A; Mancardi G Neurol Sci; 2009 Oct; 30 Suppl 2():S175-7. PubMed ID: 19882370 [TBL] [Abstract][Full Text] [Related]
5. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience. Fassas A; Kimiskidis VK J Neurol Sci; 2004 Aug; 223(1):53-8. PubMed ID: 15261561 [TBL] [Abstract][Full Text] [Related]
6. [Autotransplantation of hematopoietic progenitor cells in multiple sclerosis]. Fernández J; Correale J; Campestri R; Koziner B Medicina (B Aires); 1999; 59(3):287-92. PubMed ID: 10451571 [TBL] [Abstract][Full Text] [Related]
7. Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile? Fassas A; Mancardi GL Autoimmunity; 2008 Dec; 41(8):601-10. PubMed ID: 18958762 [TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures. Karussis D; Slavin S J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562 [TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support. Cohen Y; Nagler A Isr Med Assoc J; 2002 Nov; 4(11 Suppl):865-7. PubMed ID: 12455162 [No Abstract] [Full Text] [Related]
10. Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosis. Atkins H; Freedman M Methods Mol Biol; 2009; 549():231-46. PubMed ID: 19378207 [TBL] [Abstract][Full Text] [Related]
11. Nonmyeloablative stem cell transplantation for chronic myeloid leukemia. Qazilbash MH; Giralt SA; Champlin RE Hematol Oncol Clin North Am; 2004 Jun; 18(3):703-13, xi. PubMed ID: 15271401 [TBL] [Abstract][Full Text] [Related]
12. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. Capello E; Saccardi R; Murialdo A; Gualandi F; Pagliai F; Bacigalupo A; Marmont A; Uccelli A; Inglese M; Bruzzi P; Sormani MP; Cocco E; Meucci G; Massacesi L; Bertolotto A; Lugaresi A; Merelli E; Solari A; Filippi M; Mancardi GL; Neurol Sci; 2005 Dec; 26 Suppl 4():S200-3. PubMed ID: 16388358 [TBL] [Abstract][Full Text] [Related]
14. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296 [TBL] [Abstract][Full Text] [Related]
15. Role of stem cell transplantation. Harousseau JL Hematol Oncol Clin North Am; 2007 Dec; 21(6):1157-74, x. PubMed ID: 17996593 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis. Xu J; Ji BX; Su L; Dong HQ; Sun XJ; Liu CY Chin Med J (Engl); 2006 Nov; 119(22):1851-5. PubMed ID: 17134581 [TBL] [Abstract][Full Text] [Related]
17. [Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis]. Saiz A; Blanco Y; Berenguer J; Gómez-Choco M; Carreras E; Arbizu T; Graus F Neurologia; 2008 Sep; 23(7):405-7. PubMed ID: 18726717 [TBL] [Abstract][Full Text] [Related]
18. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis. Shevchenko YL; Novik AA; Kuznetsov AN; Afanasiev BV; Lisukov IA; Kozlov VA; Rykavicin OA; Ionova TI; Melnichenko VY; Fedorenko DA; Kulagin AD; Shamanski SV; Ivanov RA; Gorodokin G Exp Hematol; 2008 Aug; 36(8):922-8. PubMed ID: 18468768 [TBL] [Abstract][Full Text] [Related]
19. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Saccardi R; Tyndall A; Coghlan G; Denton C; Edan G; Emdin M; Farge D; Fassas A; Finke J; Furst D; Lassus M; Mancardi G; Miniati I; Mini E; Pagliai F; Passweg J; Pignone A; van Laar JM; Bocelli-Tyndall C; Matucci-Cerinic M Bone Marrow Transplant; 2004 Nov; 34(10):877-81. PubMed ID: 15517007 [TBL] [Abstract][Full Text] [Related]